Pancreas Cancer Studies
The Cancer Institute collaborates with Benaroya Research Institute and the Digestive Disease Institute to offer pancreas cancer studies in conjunction with providers within the Pancreatic Center of Excellence.
Currently enrolling clinical research studies related to pancreas cancer:
- Activity of TAK-931 Single Agent in Patients with Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer
- Alternating neoadjuvant Gemcitabine-Nab-Paclitaxel and nal-IRI with 5-Fluorouracil and folinic acid (Leucovorin) regimens in resectable and borderline resectable pancreatic cancer, A Pilot Study
- GEMCITABINE AND NAB-PACLITAXEL IN PANCREATIC ADENOCARCINOMA WITH POSITIVE PERITONEAL CYTOLOGY AS A SOLE METASTATIC SITE, A PILOT STUDY
If you would like to talk with a clinical research coordinator about clinical research trials related to pancreas cancer, call the Cancer Clinical Research Unit Research hotline at (206) 287-6270.
If you would like to learn about clinical trials in pancreas cancer across the country, view the PanCan Clinical Trials.